VanEck Pharmaceutical ETF
62 hedge funds and large institutions have $195M invested in VanEck Pharmaceutical ETF in 2015 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 19 increasing their positions, 18 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
6% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 18
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
62
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$49M | |
| 2 | +$24.8M | |
| 3 | +$5.44M | |
| 4 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
+$4.2M |
| 5 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
+$2.1M |
Top Sellers
| 1 | -$794K | |
| 2 | -$686K | |
| 3 | -$325K | |
| 4 |
SWA
SFMG Wealth Advisors
Plano,
Texas
|
-$212K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$195K |